Skip to main content
. 2020 Jan 8;11:130. doi: 10.1038/s41467-019-13922-8

Table 1.

Baseline characteristics of the development and clinical validation datasets.

Characteristics Development set Primary clinical validation set Secondary clinical validation set
Dataset Thailand dataset Thailand dataset EyePACS-DME dataset
Number of patients 4035 697 554
Number of fundus images 6039 1033 990
Camera used for fundus images Kowa VX-10 Kowa VX-10 Canon CR-DGi
OCT device used for determining ci-DME Heidelberg Spectralis Heidelberg Spectralis Optovue iVue
Age: mean, years (SD)

55.6 (10.8)

n = 6038

55.8 (10.8)

n = 1033

62.0 (9.8)

n = 990

Gender (% male)

60.8%

n = 6036

62.4%

n = 1031

50.1%

n = 990

Central retinal thickness: mean, μm (SD)

263.8 (146.5)

n = 6039

258.4 (132.8)

n = 1033

254.4 (56.3)

n = 990

ci-DME, Center Point Thickness ≥ 250 μm in Thailand dataset. Central Subfield Thickness ≥ 300 μm in the Eyepacs-DME dataset

28.3%

n = 6039

27.2%

n = 1033

7.8%

n = 990

Subretinal fluid presence

15.7%

n = 6039

15.1%

n = 1033

NA
Intraretinal fluid presence

45.5%

n = 6039

46.3%

n = 1033

NA

It is noteworthy that the difference between total n and subcategories is missing data (e.g., not all images had age or sex)